IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly.
about
Macrophage Migration Inhibitory Factor in Clinical Kidney DiseaseSecondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damageKlotho in cardiovascular disease: Current and future perspectivesGlucose in the dialysate: historical perspective and possible implications?A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directionsEnhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidney.Juvenile elastic arteries after 28 years of renal replacement therapy in a patient with complete complement C4 deficiencyTryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers.Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophyCholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse.Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).The relationship between IL-10 levels and cardiovascular events in patients with CKD.Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipientsEvidence for anti-inflammatory effects of exercise in CKD.The relationship between deiodinase activity and inflammatory responses under the stimulation of uremic toxins.CCR5Δ32 genotype leads to a Th2 type directed immune response in ESRD patients.Tumor necrosis factor alpha -238 G/A and -308 G/A polymorphisms and soluble TNF-α levels in chronic kidney disease: correlation with clinical variablesDeficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia.TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.Obesity related alterations in plasma cytokines and metabolic hormones in chimpanzees.Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C.Functional status and survival after kidney transplantation.Association of response to hepatitis B vaccination and survival in dialysis patientsSericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental studyHormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes.Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics.Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease.Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study.A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patientsUric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.Alteration of human blood cell transcriptome in uremia.Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients.A2B adenosine receptor-mediated induction of IL-6 promotes CKD.The uremic toxin indoxyl sulphate enhances macrophage response to LPS.Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.Evidence that p-cresol and IL-6 are adsorbed by the HFR cartridge: towards a new strategy to decrease systemic inflammation in dialyzed patients?
P2860
Q26767479-1B1EBF2D-2551-48E9-97C8-794E35826AE5Q26770744-14D9FC01-F7AF-41DB-861E-CF0B1D13AC57Q26775409-7D01F39C-E330-4B93-B64E-B24EDC266F12Q30445919-900A9FDC-8DC3-4C73-B98F-D71E9568ED51Q30491777-414F42B8-29ED-4D7D-B00A-BFD102D0F313Q30494903-982DCE4D-6BB0-43F3-9636-929B3A288BD7Q31107558-34FF7C59-5BFE-4A26-BA82-E94BD0BA6620Q33585122-E4697869-5895-4899-A8C0-97F871669D5AQ33611989-6BA0E148-12EA-459F-8502-2F1A0AA58148Q33702390-45A4CC3E-10A2-4C91-B629-3D163D1C965AQ33711270-C65DA24B-4AF0-4FF6-B2DB-0B1E44C86FAEQ33778006-31EE65EF-C4C8-49BD-B692-96B99AFD320AQ33780032-179E12BD-1148-41B8-B10D-F3AF6A3B9A53Q33835698-4D1B6530-AA0B-4515-B813-491CCE59D351Q33932079-D7E0148C-7DD1-440D-A7B6-F25D71F0EA6DQ34103416-BA91E0D5-A8D0-4F2B-AA47-F87F91BC6E6BQ34136167-DC4E4B6A-842C-4D69-9720-0054538E8D8EQ34163444-0C8A064F-1FD7-493C-8E8F-62995A74135EQ34167112-04F9C8B7-2A27-4A45-A533-4C44ED72E33CQ34170314-DA3A8DB7-DA3E-4AA5-8814-A444BEC79657Q34180765-DC5E4826-F618-4708-87B6-7B7DABE84941Q34278709-2F4AF659-9583-4A15-AC9C-E0AB992748F3Q34329340-1225C4C1-CE42-44BF-B5A0-3EC50AA9D7BDQ34376744-2E20BCD3-058F-4877-89AF-4934556C7595Q34398430-13866D17-2DA4-4DFE-8575-5457A5B72DDBQ34420464-D5CE332D-2C63-41EF-A1C0-1711C5727616Q34501801-1A431B60-B8FE-4622-BB33-FF34C574F4AFQ34602194-671B41F1-D19F-4D41-A7AF-CFEDC5DCF7EAQ34612908-4E112B39-11A0-4284-8989-3AC5CB209C81Q34655118-142A9FCA-3B85-4DE8-B2DB-7CA885B77E30Q34714685-67496875-D3D8-4F8C-842E-9EA7E894C84EQ34724967-D0419812-1757-4780-A3CF-6DE649B26FA5Q34786583-CBC18DCE-0A8B-4197-BE59-F37FCAB0F586Q34813421-ABCF6057-4C76-4114-B1A1-810D2A28A5C3Q34857624-A48328F5-817E-4141-9EE9-77C8FF0BE8C2Q34870775-C4B104ED-4733-479A-8AD0-0ECA403FDF66Q35010395-4BA82D24-CF3A-4B2C-8E7E-56B5990FB9A1Q35051231-3C9C2EBC-3A15-4FC6-B9D7-0C870A9FCEA1Q35131398-25930887-24B2-4BE7-8746-EF435529DD1CQ35154864-4183AE89-1288-4086-A027-C28E9C4A579E
P2860
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@ast
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@en
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@nl
type
label
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@ast
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@en
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@nl
prefLabel
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@ast
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@en
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@nl
P2093
P50
P1433
P1476
IL-10, IL-6, and TNF-alpha: ce ...... e good, the bad, and the ugly.
@en
P2093
Markus Ketteler
Miguel Riella
Richard J Johnson
Tommy Cederholm
P304
P356
10.1111/J.1523-1755.2005.00200.X
P407
P577
2005-04-01T00:00:00Z
P5875
P6179
1053359290